Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and WNT-pathway-related markers of bowel cancer risk.

Bowel cancer Bowel cancer risk WNT signalling pathway World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations

Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
14 09 2019
Historique:
pubmed: 27 9 2018
medline: 28 5 2020
entrez: 27 9 2018
Statut: ppublish

Résumé

Bowel cancer risk is strongly influenced by lifestyle factors including diet and physical activity. Several studies have investigated the effects of adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) cancer prevention recommendations on outcomes such as all-cause and cancer-specific mortality, but the relationships with molecular mechanisms that underlie the effects on bowel cancer risk are unknown. This study aimed to investigate the relationships between adherence to the WCRF/AICR cancer prevention recommendations and wingless/integrated (WNT)-pathway-related markers of bowel cancer risk, including the expression of WNT pathway genes and regulatory microRNA (miRNA), secreted frizzled-related protein 1 (SFRP1) methylation and colonic crypt proliferative state in colorectal mucosal biopsies. Dietary and lifestyle data from seventy-five healthy participants recruited as part of the DISC Study were used. A scoring system was devised including seven of the cancer prevention recommendations and smoking status. The effects of total adherence score and scores for individual recommendations on the measured outcomes were assessed using Spearman's rank correlation analysis and unpaired t tests, respectively. Total adherence score correlated negatively with expression of Myc proto-oncogene (c-MYC) (P=0·039) and WNT11 (P=0·025), and high adherers had significantly reduced expression of cyclin D1 (CCND1) (P=0·042), WNT11 (P=0·012) and c-MYC (P=0·048). Expression of axis inhibition protein 2 (AXIN2), glycogen synthase kinase (GSK3β), catenin β1 (CTNNB1) and WNT11 and of the oncogenic miRNA miR-17 and colonic crypt kinetics correlated significantly with scores for individual recommendations, including body fatness, red meat intake, plant food intake and smoking status. The findings from this study provide evidence for positive effects of adherence to the WCRF/AICR cancer prevention recommendations on WNT-pathway-related markers of bowel cancer risk.

Identifiants

pubmed: 30255827
pii: S0007114518002520
doi: 10.1017/S0007114518002520
pmc: PMC6330067
mid: EMS79002
doi:

Substances chimiques

Biomarkers, Tumor 0
MAS1 protein, human 0
Proto-Oncogene Mas 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-517

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/H005013/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L016354/1
Pays : United Kingdom

Références

Am J Clin Nutr. 2013 May;97(5):1107-20
pubmed: 23553166
Int J Cancer. 2009 May 15;124(10):2406-15
pubmed: 19142968
Int J Cancer. 2017 Jul 1;141(1):83-93
pubmed: 28380695
BMJ. 2011 Nov 10;343:d6617
pubmed: 22074852
Gut. 1993 Apr;34(4):525-30
pubmed: 8491402
Cancer. 1991 Aug 15;68(4):873-8
pubmed: 1855187
Cancer Causes Control. 2014 May;25(5):541-52
pubmed: 24557428
Cancer Causes Control. 2016 Nov;27(11):1347-1359
pubmed: 27752849
Int J Epidemiol. 1997;26 Suppl 1:S137-51
pubmed: 9126542
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14973-8
pubmed: 11752446
Aging (Albany NY). 2018 May 18;10(5):1000-1014
pubmed: 29779016
Nat Rev Cancer. 2008 May;8(5):387-98
pubmed: 18432252
Int J Mol Med. 2001 Dec;8(6):651-6
pubmed: 11712081
Gut. 2012 Jul;61(7):1041-9
pubmed: 21948946
Am J Clin Nutr. 2017 Feb;105(2):400-410
pubmed: 28077379
Am J Clin Nutr. 2016 Sep;104(3):678-85
pubmed: 27488239
Am J Clin Nutr. 1999 Oct;70(4):439-47
pubmed: 10500011
Aging Cell. 2013 Feb;12(1):148-55
pubmed: 23157586
Am J Clin Nutr. 2012 Jul;96(1):150-63
pubmed: 22592101
World J Gastroenterol. 2006 Nov 28;12(44):7113-7
pubmed: 17131472
Biochem Biophys Res Commun. 2005 Sep 9;334(4):1365-73
pubmed: 16043125
Gastroenterology. 2012 Feb;142(2):219-32
pubmed: 22155636
Gut. 2009 Mar;58(3):413-20
pubmed: 18978177
Mol Carcinog. 2013 Mar;52(3):207-17
pubmed: 22161723
Mol Cell Biol. 2002 Feb;22(4):1184-93
pubmed: 11809809
Eur J Cancer. 2017 Nov;85:86-94
pubmed: 28892777
BMC Med. 2015 May 07;13:107
pubmed: 25948112
Br J Nutr. 2018 Feb;119(3):340-348
pubmed: 29352814
Gastroenterology. 2005 Aug;129(2):626-38
pubmed: 16083717
Am J Pathol. 2002 Feb;160(2):389-401
pubmed: 11839557
PLoS One. 2014 Apr 11;9(4):e94508
pubmed: 24728073
Clin Cancer Res. 2012 Oct 15;18(20):5546-53
pubmed: 23071356
Br J Cancer. 2009 Aug 18;101(4):707-14
pubmed: 19672269
Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
pubmed: 21037809
Sci Rep. 2016 Feb 10;6:21520
pubmed: 26861754
Cancer Causes Control. 2015 Feb;26(2):277-286
pubmed: 25559553
Cancer Prev Res (Phila). 2014 Aug;7(8):786-95
pubmed: 25092886
Gut. 2001 Jan;48(1):41-6
pubmed: 11115821
Br J Cancer. 1986 Jan;53(1):1-6
pubmed: 3511934

Auteurs

Fiona C Malcomson (FC)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Naomi D Willis (ND)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Iain McCallum (I)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Long Xie (L)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Seamus Kelly (S)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

David Michael Bradburn (DM)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Nigel J Belshaw (NJ)

Quadram Institute, Norwich Research Park, Norwich, NorfolkNR4 7UA, UK.

Ian T Johnson (IT)

Quadram Institute, Norwich Research Park, Norwich, NorfolkNR4 7UA, UK.

John C Mathers (JC)

Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon TyneNE2 4HH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH